Protagonist Therapeutics, Inc: cashflow_financing

Value{"amount": 7199000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2024-01-01 – 2024-03-31
Statuscurrent
EntityProtagonist Therapeutics, Inc
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-24-007081
Retrieved: 2026-08-19T13:14:38.425290+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001377121/cashflow-financing/2024-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/85118234-6a50-44d6-bcf8-d32cdd6e7c59

History